Auro Pharma Losartan product recall (2021-10-12)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
A. Auro-Losartan HCT 50mg/12.5mg
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| ACO1021003A, QY1018012-B, QY1018013-A, QY1018014-A, QY1018015-A, QY1019009-D, QY1018010-A, QY1018011-A, QY1018012-A, QY1019009-A | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| Auro-Losartan HCT 100mg/12.5mg | DIN 02423650 | Tablet | Losartan Potassium 100mg Hydrochlorothiazide 12.5mg |
| ACI1021007A, QX1019011-A, QX1019010-B, QX1019008-A, QX1019009-B, QX1019007-A | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| Auro-Losartan HCT 100mg/25mg | DIN 02423669 | Tablet | Losartan Potassium 100mg Hydrochlorothiazide 25mg |
| ACI5021007E, QX5019009-C, QX5019010-A, QX5019011-E, QX5019009-B | - Recalling Firm
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
- Marketing Authorization Holder
- Auro Pharma Inc.
- 3700 Steeles Ave. W
- Woodbridge
- L4L 8K8
- Ontario
- CANADA
| Auro-Losartan HCT 50mg/12.5mg | DIN 02423642 | Tablet | Losartan Potassium 50mg Hydrochlorothiazide 12.5mg |
A. Auro-Losartan HCT 50mg/12.5mg
B. Auro-Losartan HCT 100mg/12.5mg
C. Auro-Losartan HCT 100mg/25mg
Presence of impurity (5-(4 '- ((5 - (Azidomethyl) -2-butyl-4-chloro-1H-imidazol-1-yl) methyl)-[1,1' - biphenyl] - 2-yl) - 1H-tetrazole above the acceptable concentration limit in affected lots.
Wholesalers, Retailers, Healthcare Establishments